Higher doses are not associated with a safety risk, the FDA said Nov. 1, and no serious adverse effects have been reported.
“[The] FDA has become aware that some healthcare providers may not recognize that the single dose vial of Moderna COVID-19 Vaccine (2023-2024 Formula) for use in individuals 6 months through 11 years of age contains notably more than 0.25 mL of the vaccine,” the Nov. 1 warning said. “Some healthcare providers may be withdrawing the entire contents of the vial to administer to an individual” even though the approved dosage is 0.25 milliliters.
Excess solution from the vial should be discarded, the agency said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
